Type 2 Diabetes Clinical Trial
— Ex nit asOfficial title:
The Effect of Dietary Nitrate Supplementation on Ability of Individuals With Type 2 Diabetes to Perform Exercise
| NCT number | NCT02206074 |
| Other study ID # | CRF107 |
| Secondary ID | 12/SW/0118 |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 2012 |
| Est. completion date | August 2013 |
| Verified date | March 2019 |
| Source | University of Exeter |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The investigators are conducting a research study to see if increasing the amount of nitrate
(a substance found in large quantities in certain vegetables) in the diet can increase the
ability of individuals with Type 2 diabetes (T2D) to perform exercise. Some people with T2D
find exercise more uncomfortable than individuals who do not have T2D. This may be explained
by the experimental studies showing that T2D can result in reductions in the supply of oxygen
to the muscles. Studies have also shown that for a given level of activity, individuals with
T2D will be much closer to their maximum exercise capacity than healthy individuals. Dietary
nitrate may have two important beneficial effects in individuals with T2D: 1) The effects of
dietary nitrate on the responses to exercise may have a significant impact on the ability of
individuals with Type 2 diabetes to perform daily tasks and exercise more comfortably and 2)
experimental studies suggest that increased nitrate consumption has been shown to reduce the
amount of oxygen required for a given level of exercise.
The investigators will recruit 60 individuals with T2D. These people will take part in a
randomised crossover design study where they will be asked to drink normal beetroot juice
(rich in nitrate) and nitrate depleted beetroot juice, prior to performing two different
walking exercise tasks (a six minute walk and repeated, low intensity treadmill walking).
This study aims to determine if dietary nitrate supplementation reduces the amount of oxygen
required for a given level of exercise in individuals with T2D. To test brain function
individuals will be asked to perform a standard computerised decision making task following
consumption of the nitrate rich and nitrate depleted juices.
| Status | Completed |
| Enrollment | 57 |
| Est. completion date | August 2013 |
| Est. primary completion date | August 2013 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 35 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - patients with T2D (as defined by WHO) of at least 5 years duration between the ages of 35-75 will be invited. Exclusion Criteria: - patients with significant renal impairment (eGFR<30) - uncontrolled hypertension - BMI<25 or >35 - are taking regular organic nitrates, nicorandil, or thiazolidinidiones, or any medication which may interfere with data interpretation or safety - who have had a myocardial infarction or cerebro-vascular event - who smoke, or any other serious medical condition which would interfere with data interpretation or safety will be excluded from participation. |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Peninsula NIHr Exeter Clinical Research Facility | Exeter | Devon |
| Lead Sponsor | Collaborator |
|---|---|
| University of Exeter | Diabetes UK |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Pulmonary gas exchange via MedGraphics CardiO2 Cardiopulmonary Diagnostic Systems | Pulmonary gas exchange was measured during treadmill walking exercise (MedGraphics CardiO2 Cardiopulmonary Diagnostic Systems, St. Paul, MN, USA). Prior to each testing session the analysers were calibrated using known concentrations. The volume transducer was calibrated using a 3-litre syringe (Hans Rudolph, Kansas City, MO, USA). When we refer to the oxygen cost of exercise we are referring to end exercise oxygen uptake. | 3 x 6 minutes of gas exchange per participant, twice, 10-14 days apart | |
| Secondary | Functional capacity measured by 6-Minute Walking Test (6MWT) | 6 minutes walking per participant per visit |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |